{"id":6641,"date":"2017-08-12T17:32:47","date_gmt":"2017-08-12T17:32:47","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/esho-2024-andromedic\/"},"modified":"2026-02-17T08:45:46","modified_gmt":"2026-02-17T08:45:46","slug":"esho-2024-andromedic","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/nl\/esho-2024-andromedic\/","title":{"rendered":"ESHO 2024 &#8211; Andromedische deelname"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"WebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/nl\/esho-2024-andromedic\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/nl\/esho-2024-andromedic\/\",\n      \"name\": \"ESHO 2024 M\u00e1laga: Wetenschappelijke inzichten van Andromedic & SIIO\",\n      \"description\": \"Wetenschappelijke inzichten van ESHO 2024 M\u00e1laga. Andromedic presenteert het SIIO-abstract over de ontwikkeling van oncologische hyperthermie.\",\n      \"inLanguage\": \"nl-NL\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \/* MASTER GRAPH LINK *\/\n      \"about\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\" }\n    },\n    {\n      \"@type\": \"MedicalScholarlyArticle\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/nl\/esho-2024-andromedic\/#article\",\n      \"headline\": \"Italiaanse Vereniging voor Oncologische Hyperthermie (SIIO): oprichting, activiteiten en toekomstige projecten\",\n      \"author\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/ciro-zaccagnini-ceo\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\" }\n      ],\n      \"publisher\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n      \/* MAIN KEYWORD SYNC: HyDeep 600WM *\/\n      \"keywords\": \"ESHO 2024, oncologische hyperthermie, SIIO, SRHO, HyDeep 600WM\",\n      \"about\": [\n         { \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\" },\n         { \"@id\": \"https:\/\/andromedichyperthermia.com\/#srho\" }\n      ]\n    },\n    {\n      \"@type\": [\"Product\", \"MedicalDevice\"],\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\",\n      \"name\": \"HyDeep 600WM\",\n      \"brand\": { \"@type\": \"Brand\", \"name\": \"Andromedic\" },\n      \"image\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/HyDeep-600WM-Andromedic.jpg\",\n      \"description\": \"Geavanceerd oncologisch hyperthermiesysteem \/ professioneel apparaat voor gemoduleerde RF-hyperthermie (13,56 MHz).\",\n      \"offers\": {\n        \"@type\": \"Offer\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/nl\/contact\/\",\n        \"price\": \"0\",\n        \"priceCurrency\": \"EUR\",\n        \"availability\": \"https:\/\/schema.org\/InStock\",\n        \"priceSpecification\": {\n          \"@type\": \"PriceSpecification\",\n          \"description\": \"Prijs op aanvraag\"\n        }\n      },\n      \"review\": {\n        \"@type\": \"Review\",\n        \"author\": { \"@type\": \"Person\", \"name\": \"Dr. med. Veronica Iatan\" },\n        \"reviewRating\": { \"@type\": \"Rating\", \"ratingValue\": \"5\", \"bestRating\": \"5\" },\n        \"reviewBody\": \"Toonaangevende technologie voor diepe hyperthermie met klinisch gevalideerde protocollen.\"\n      }\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Srl\"\n    }\n  ]\n}\n<\/script><\/p>\n<div style=\"line-height: 1.6; color: #1d1d1f; max-width: 1100px; margin: auto; font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif; background-color: #fff; padding: 20px;\">\n<header style=\"text-align: center; padding: 60px 20px; background: linear-gradient(135deg, #f5f5f7 0%, #e8e8ed 100%); border-radius: 24px; margin-bottom: 40px; box-shadow: 0 10px 30px rgba(0,0,0,0.05);\">\n<h1 style=\"color: #1a2a6c; font-size: 38px; font-weight: 800; margin-bottom: 10px; letter-spacing: -0.5px;\">European Society for Hyperthermic Oncology Congress<\/h1>\n<h2 style=\"color: #b21f1f; font-size: 24px; font-weight: 600; margin-top: 0;\">ESHO 2024 M\u00e1laga | Geavanceerde Oncologische Hyperthermie<\/h2>\n<\/header>\n<div style=\"margin-bottom: 40px; text-align: center;\">\n<p><img loading=\"lazy\" decoding=\"async\" width=\"2560\" height=\"533\" class=\"size-full wp-image-522\" style=\"width: 100%; border-radius: 20px; box-shadow: 0 20px 40px rgba(0,0,0,0.1);\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO2024-Banner-Startseite-scaled.jpg\" alt=\"ESHO 2024 M\u00e1laga Spanje Conferentie - Toekomst van Thermotherapie\" title=\"\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO2024-Banner-Startseite-scaled.jpg 2560w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO2024-Banner-Startseite-300x63.jpg 300w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO2024-Banner-Startseite-1024x213.jpg 1024w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO2024-Banner-Startseite-768x160.jpg 768w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO2024-Banner-Startseite-1536x320.jpg 1536w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO2024-Banner-Startseite-2048x427.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/p>\n<p style=\"font-size: 14px; color: #86868b; margin-top: 15px;\">ESHO 2024 &#8211; M\u00e1laga, Spanje: Presentatie van de toekomst van thermotherapie.<\/p>\n<\/div>\n<section style=\"background: linear-gradient(135deg, #001e30 0%, #004a7c 100%); color: #fff; padding: 35px; border-radius: 24px; margin-bottom: 40px; box-shadow: 0 15px 35px rgba(0,74,124,0.2); text-align: center;\">\n<p style=\"font-size: 19px; margin: 0; opacity: 0.9;\">Het <strong>Andromedic Team<\/strong>, vertegenwoordigd door<br \/>\n<a style=\"color: #fff; font-weight: bold; text-decoration: underline;\" href=\"https:\/\/andromedichyperthermia.com\/zh-hans\/doctor-salvatore-conte\/\">Salvatore Conte<\/a> &amp; <strong>Ciro Zaccagnini (CEO)<\/strong>, nam deel aan de:<\/p>\n<h3 style=\"font-size: 24px; margin-top: 20px;\"><a style=\"color: #0071e3; background: #fff; padding: 10px 20px; border-radius: 50px; text-decoration: none; font-weight: bold; display: inline-block; margin-top: 10px;\" href=\"https:\/\/esho-congress.eu\/\" target=\"_blank\" rel=\"noopener\">36e Jaarvergadering van de ESHO (2024)<\/a><\/h3>\n<\/section>\n<div style=\"text-align: center; margin-bottom: 50px;\">\n<p><img loading=\"lazy\" decoding=\"async\" width=\"2000\" height=\"1333\" class=\"size-full wp-image-50\" style=\"width: 100%; max-width: 950px; border-radius: 20px; border: 1px solid #d2d2d7; box-shadow: 0 10px 20px rgba(0,0,0,0.05);\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO_2024_-_Andromedic-team-OncoTherm-team-etc.jpg\" alt=\"Salvatore Conte en Ciro Zaccagnini met het Andromedic-team bij ESHO 2024\" title=\"\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO_2024_-_Andromedic-team-OncoTherm-team-etc.jpg 2000w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO_2024_-_Andromedic-team-OncoTherm-team-etc-300x200.jpg 300w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO_2024_-_Andromedic-team-OncoTherm-team-etc-768x512.jpg 768w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO_2024_-_Andromedic-team-OncoTherm-team-etc-1536x1024.jpg 1536w\" sizes=\"auto, (max-width: 2000px) 100vw, 2000px\" \/><\/p>\n<p style=\"font-size: 14px; color: #86868b; margin-top: 15px;\">ESHO 2024 &#8211; Salvatore Conte, Ciro Zaccagnini, het OncoTherm-team en internationale medewerkers.<\/p>\n<\/div>\n<article style=\"background: #fff; border: 1px solid #d2d2d7; border-radius: 24px; padding: 45px; box-shadow: 0 4px 12px rgba(0,0,0,0.03);\">\n<h2 style=\"color: #1a2a6c; border-bottom: 1px solid #d2d2d7; padding-bottom: 20px; margin-bottom: 30px; font-size: 28px; font-weight: bold;\">Gepresenteerd Abstract<\/h2>\n<h3 style=\"font-size: 22px; color: #b21f1f; line-height: 1.4; margin-bottom: 25px; font-weight: 600;\">Italiaanse Vereniging voor Oncologische Hyperthermie (Societ\u00e0 Italiana di Ipertermia Oncologica &#8211; SIIO): Oprichting, activiteiten en toekomstige projecten voor de ontwikkeling van thermotherapie en hyperthermie in Itali\u00eb<\/h3>\n<div style=\"background: #f5f5f7; padding: 25px; border-radius: 15px; margin-bottom: 35px; font-size: 15px; border-left: 4px solid #0071e3;\">\n<p><strong style=\"color: #1d1d1f; display: block; margin-bottom: 10px;\">Auteurs:<\/strong> G. Fiorentini<sup>1<\/sup>, G. Ranieri<sup>2<\/sup>, M. Bonucci<sup>3<\/sup>, S. Bonanno<sup>4<\/sup>, G. Cristina<sup>5<\/sup>, R. Lodico<sup>6<\/sup>, D. Sarti<sup>7<\/sup><\/p>\n<ol style=\"font-size: 13px; color: #424245; line-height: 1.6; margin-top: 10px; padding-left: 20px;\">\n<li>San Salvatore Hospital, Oncologie, Pesaro, Itali\u00eb<\/li>\n<li>Nationaal Kankerinstituut, Oncologie, Bari, Itali\u00eb<\/li>\n<li>ARTOI Foundation, Integratieve Oncologie, Roma, Itali\u00eb<\/li>\n<li>Regionaal Ziekenhuis, Radiotherapie, Siracusa, Itali\u00eb<\/li>\n<li>Regionaal Ziekenhuis, Interne Geneeskunde &#8211; Complementaire Geneeskunde, Merano, Itali\u00eb<\/li>\n<li>San Camillo Forlanini, Chirurgische Oncologie, Roma, Itali\u00eb<\/li>\n<li>Oncologie Unit, Urbino, Itali\u00eb<\/li>\n<\/ol>\n<\/div>\n<div style=\"font-size: 17px; line-height: 1.8; color: #1d1d1f;\">\n<p>De <strong>Italiaanse Vereniging voor Oncologische Hyperthermie (SIIO)<\/strong> werd in september 2023 opgericht om oncologische hyperthermie in Itali\u00eb te promoten en op nationaal grondgebied te ontwikkelen, om kankerpati\u00ebnten beter van dienst te kunnen zijn.<\/p>\n<h4 style=\"color: #1a2a6c; margin-top: 30px; font-size: 20px; font-weight: 600;\">Methoden<\/h4>\n<p>SIIO rekruteert momenteel 20 centra, waaronder openbare ziekenhuizen en priv\u00e9klinieken. Alle hyperthermiecentra hebben ingestemd met de voorgestelde statuten en de ethische code van SIIO. De volgende thema&#8217;s zijn goedgekeurd:<\/p>\n<ul style=\"padding-left: 25px; color: #424245;\">\n<li>Bevordering van kennis over <strong>Thermotherapie<\/strong> via publicaties en educatieve symposia.<\/li>\n<li>Bevordering van Hyperthermie in alle medische wetenschappen.<\/li>\n<li>Facilitering van co\u00f6peratief onderzoek tussen <strong>fysica, engineering, biologie, chemie en geneeskunde<\/strong> naar de effecten van hyperthermie.<\/li>\n<li>Organisatie van een nationale database voor tumoren behandeld met hyperthermie (stadium, resultaten, overleving).<\/li>\n<li>Defini\u00ebren van nieuwe <strong>ge\u00efntegreerde protocollen (Fase II en III)<\/strong> zoals chemo-hyperthermie en radio-hyperthermie.<\/li>\n<\/ul>\n<h4 style=\"color: #1a2a6c; margin-top: 30px; font-size: 20px; font-weight: 600;\">Resultaten<\/h4>\n<p>Jaarlijks worden in Itali\u00eb ongeveer <strong>drieduizend pati\u00ebnten<\/strong> behandeld met hyperthermie (86% in priv\u00e9klinieken, 14% in openbare ziekenhuizen), voornamelijk in de gemetastaseerde fase met een levensverwachting van 3 tot 24 maanden.<\/p>\n<p>Elke pati\u00ebnt ontving gemiddeld <strong>elf hyperthermiesessies<\/strong> met gebruik van verschillende apparaten, waaronder de <strong>HyDeep 600 WM<\/strong> van <strong>Andromedic<\/strong>. De behandelduur bedroeg 55 minuten met 2-3 sessies per week. 90% van de pati\u00ebnten ontving aanvullende integratieve therapie\u00ebn, waarbij bijzondere aandacht werd besteed aan de kwaliteit van leven via de <strong>ESAS-schaal<\/strong>.<\/p>\n<h4 style=\"color: #1a2a6c; margin-top: 30px; font-size: 20px; font-weight: 600;\">Conclusies<\/h4>\n<p>SIIO streeft naar de uitbreiding van het therapeutisch paradigma door training van gespecialiseerde artsen en technici. De vereniging werkt samen met het <strong>Italiaanse Ministerie van Volksgezondheid<\/strong> om de toegang van pati\u00ebnten tot hyperthermiebehandelingen in heel Europa te optimaliseren.<\/p>\n<\/div>\n<\/article>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>European Society for Hyperthermic Oncology Congress ESHO 2024 M\u00e1laga | Geavanceerde Oncologische Hyperthermie ESHO 2024 &#8211; M\u00e1laga, Spanje: Presentatie van de toekomst van thermotherapie. Het Andromedic Team, vertegenwoordigd door Salvatore Conte &amp; Ciro Zaccagnini (CEO), nam deel aan de: 36e Jaarvergadering van de ESHO (2024) ESHO 2024 &#8211; Salvatore Conte, Ciro Zaccagnini, het OncoTherm-team en&hellip;<\/p>\n","protected":false},"author":1,"featured_media":6643,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-gutentor-full-width.php","meta":{"footnotes":""},"class_list":["post-6641","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/nl\/wp-json\/wp\/v2\/pages\/6641","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/nl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/nl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/nl\/wp-json\/wp\/v2\/comments?post=6641"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/nl\/wp-json\/wp\/v2\/pages\/6641\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/nl\/wp-json\/wp\/v2\/media\/6643"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/nl\/wp-json\/wp\/v2\/media?parent=6641"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}